PDCA循环管理对降低质子泵抑制剂临床不合理用药的效果分析及其对策

Analysis on Efficacy of PDCA Cycle Management in Reducing Clinical Unreasonable Usage of Proton Pump Inhibitors and Its Countermeasures

目的:分析PDCA循环管理对降低质子泵抑制剂(PPIs)临床不合理用药的效果及其对策,为规范质子泵抑制剂临床合理使用提供参考。方法:抽取2017年第4季度使用质子泵抑制剂的住院患者医嘱50份为PDCA管理干预前组;另抽取2018年第1、2、3、4季度使用质子泵抑制剂的住院患者医嘱200份为PDCA管理干预后组,分析其医嘱中使用质子泵抑制剂合理用药的专项点评,比较干预前后使用合理率差异,分析不合理使用的类型及其原因。结果:PDCA循环管理干预后,质子泵抑制剂不合理使用率从28%降至16%,其合理使用率不断上升。结论:采用PDCA循环管理干预有利于提高医院药事管理质量和药学服务水平,促进了临床合理使用质子泵抑制剂。

Objective:To analyze the efficacy of PDCA cycle management on reducing the clinical unreasonable usage of proton pump inhibitors (PPIs) and its countermeasures,and to provide a reference for standardizing the clinical rational usage of PPIs.Methods:50 pieces of medical orders of inpatients using PPIs in the fourth quarter of 2017 were selected as the PDCA management pre-intervention group.In addition,200 inpatients who used PPIs in the first,second, third and fourth quarters of 2018 were selected as the post-PDCA management intervention group,and the special comments on the rational use of PPIs in their medical orders were analyzed,and the differences in the rational use rate before and after the intervention were compared.The types and reasons of unreasonable use were analyzed.Results:After PDCA cycle management intervention,the unreasonable utilization rate of PPIs decreased from 28% to 16%,and its reasonable utilization rate continued to rise.Conclusion:PDCA cycle management intervention is beneficial to improving the quality of hospital pharmaceutical management and pharmaceutical care level,and also promoting the rational use of proton pump inhibitors in clinical practice.